Table of Content

1. Executive Summary
   1.1. Global Autism Spectrum Disorder Therapeutics Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global GDP Growth Outlook
       2.3.2. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Disease Epidemiology
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Global Autism Spectrum Disorder Therapeutics Market Outlook: Drug Therapy
       4.1.1. Introduction / Key Findings
       4.1.2. Historical Market Size (US$ Mn) Analysis, By Drug Therapy, 2018 - 2022
       4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
           4.1.3.1. Antipsychotic Drug
           4.1.3.2. Antidepressants
           4.1.3.3. Stimulants
   4.2. Market Attractiveness Analysis: Drug Therapy
   4.3. Global Autism Spectrum Disorder Therapeutics Market Outlook: Disease
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Disease, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
           4.3.3.1. Autistic Disorder
           4.3.3.2. Asperger Syndrome
           4.3.3.3. Pervasive Development Disorder
   4.4. Market Attractiveness Analysis: Disease
   4.5. Global Autism Spectrum Disorder Therapeutics Market Outlook: Age Group
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Age Group, 2018 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
           4.5.3.1. Children
           4.5.3.2. Adults
   4.6. Market Attractiveness Analysis: Age Group
5. Global Autism Spectrum Disorder Therapeutics Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.3.1. By Country
       6.3.2. By Drug Therapy
       6.3.3. By Disease
       6.3.4. By Age Group
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       6.5.1. Antipsychotic Drug
       6.5.2. Antidepressants
       6.5.3. Stimulants
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       6.6.1. Autistic Disorder
       6.6.2. Asperger Syndrome
       6.6.3. Pervasive Development Disorder
   6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       6.7.1. Children
       6.7.2. Adults
   6.8. Market Attractiveness Analysis
7. Europe Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.3.1. By Country
       7.3.2. By Drug Therapy
       7.3.3. By Disease
       7.3.4. By Age Group
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.4.1. Germany
       7.4.2. France
       7.4.3. U.K.
       7.4.4. Italy
       7.4.5. Spain
       7.4.6. Russia
       7.4.7. Türkiye
       7.4.8. Rest of Europe
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       7.5.1. Antipsychotic Drug
       7.5.2. Antidepressants
       7.5.3. Stimulants
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       7.6.1. Autistic Disorder
       7.6.2. Asperger Syndrome
       7.6.3. Pervasive Development Disorder
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       7.7.1. Children
       7.7.2. Adults
   7.8. Market Attractiveness Analysis
8. East Asia Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.3.1. By Country
       8.3.2. By Drug Therapy
       8.3.3. By Disease
       8.3.4. By Age Group
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.4.1. China
       8.4.2. Japan
       8.4.3. South Korea
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       8.5.1. Antipsychotic Drug
       8.5.2. Antidepressants
       8.5.3. Stimulants
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       8.6.1. Autistic Disorder
       8.6.2. Asperger Syndrome
       8.6.3. Pervasive Development Disorder
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       8.7.1. Children
       8.7.2. Adults
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.3.1. By Country
       9.3.2. By Drug Therapy
       9.3.3. By Disease
       9.3.4. By Age Group
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.4.1. India
       9.4.2. Southeast Asia
       9.4.3. ANZ
       9.4.4. Rest of South Asia & Oceania
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       9.5.1. Antipsychotic Drug
       9.5.2. Antidepressants
       9.5.3. Stimulants
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       9.6.1. Autistic Disorder
       9.6.2. Asperger Syndrome
       9.6.3. Pervasive Development Disorder
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       9.7.1. Children
       9.7.2. Adults
   9.8. Market Attractiveness Analysis
10. Latin America Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.3.1. By Country
       10.3.2. By Drug Therapy
       10.3.3. By Disease
       10.3.4. By Age Group
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       10.5.1. Antipsychotic Drug
       10.5.2. Antidepressants
       10.5.3. Stimulants
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       10.6.1. Autistic Disorder
       10.6.2. Asperger Syndrome
       10.6.3. Pervasive Development Disorder
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       10.7.1. Children
       10.7.2. Adults
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Autism Spectrum Disorder Therapeutics Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.3.1. By Country
       11.3.2. By Drug Therapy
       11.3.3. By Disease
       11.3.4. By Age Group
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.4.1. GCC Countries
       11.4.2. Egypt
       11.4.3. South Africa
       11.4.4. Northern Africa
       11.4.5. Rest of Middle East & Africa
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Therapy, 2023 - 2031
       11.5.1. Antipsychotic Drug
       11.5.2. Antidepressants
       11.5.3. Stimulants
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2023 - 2031
       11.6.1. Autistic Disorder
       11.6.2. Asperger Syndrome
       11.6.3. Pervasive Development Disorder
   11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2023 - 2031
       11.7.1. Children
       11.7.2. Adults
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Curemark LLC
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Bristol-Myers Squibb Company
       12.3.3. Merck & Co., Inc.
       12.3.4. Novartis AG.
       12.3.5. Eli Lilly and Company
       12.3.6. Pfizer Inc.
       12.3.7. Johnson & Johnson Services Inc.
       12.3.8. Otsuka Pharmaceutical Co., Ltd.
       12.3.9. Yamo Pharmaceuticals
       12.3.10. F. Hoffman-La Roche Ltd.
       12.3.11. Axial Therapeutics Inc.
       12.3.12. Others
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations